Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM reversal: Modular prospects for Eco Buildings

Kew Soda plans premium listing

Aquis weekly movers: Wishbone Gold awarded grant for drilling

AIM weekly movers: Rockfire Resources encounters high zinc grades

AIM Movers: New Pelatro contract and Amur Minerals considers bid

AIM movers: Westminster Security nears breakeven and ex-dividends

AIM movers: Yu Group trading ahead of expectations and no bid for Purplebricks

AIM movers: Empire Metals discovery and Woodbois requires cash

Half price assets at Seraphim Space IT

New standard listing: Oneiro Energy

Aquis weekly movers: Marula Mining moves towards copper ore processing in Tanzania

AIM weekly movers: Versarien recovers

AIM movers: High grades for Rockfire Resources and Pan African Resources reduces gold production guidance

Fevertree sales build momentum

AIM movers: Mercantile Ports contract and ex-dividends

New standard listing: Admiral Acquisition

AIM movers: Enwell Energy dividend boost

AIM movers: Southern Energy buys acreage in Mississippi and Eneraqua Technologies downgrade

Marks & Spencer upgraded ahead of results

Chill Brands UK distribution deal

AIM movers: Norman Broadbent grows revenues and Barryroe project rejected by Irish government

Aquis weekly movers: Asimilar to concentrate on Aquis quotation

AIM weekly movers: Egdon Resources agrees bid

AIM movers: IQE share price recovers and Fusion Antibodies heavily discounted fundraising

AIM movers: SRT Marine contract gain and ex-dividends

IQE seeks investment for growth sectors

Hardide progresses towards breakeven

Antenna profit boost for MTI Wireless

Frasers increases stake in ASOS

AIM movers: Egdon Resources recommends bid and Purplebricks sells business

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020